Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
SUNY Stony Brook
mi
from
Stony Brook, NY
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
SUNY Stony Brook
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
Wake Forest University
mi
from
Winston-Salem, NC
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
Cleveland Clinic
mi
from
Cleveland, OH
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
Temple University
mi
from
Philadelphia, PA
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
Brown University
mi
from
Providence, RI
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated:  7/20/2015
VCU Medical Center
mi
from
Richmond, VA
Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)
Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department
Status: Enrolling
Updated: 7/20/2015
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Cardio-Thoracic Surgeons, P.C.
mi
from
Birmingham, AL
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Cardio-Thoracic Surgeons, P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Drug Research & Analysis Corporation
mi
from
Montgomery, AL
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Drug Research & Analysis Corporation
mi
from
Montgomery, AL
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
University of Colorado Denver
mi
from
Aurora, CO
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Pepin Heart Hospital & Kiran Patel Research Institute
mi
from
Tampa, FL
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Pepin Heart Hospital & Kiran Patel Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Indiana/Ohio Heart
mi
from
Fort Wayne, IN
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Indiana/Ohio Heart
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
University of Kentucky
mi
from
Lexington, KY
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Massachusetts General Hospital
mi
from
Boston, MA
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
MCVI at Covenant Medical Center
mi
from
Saginaw, MI
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
MCVI at Covenant Medical Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
MCVI - St. Mary's of Michigan
mi
from
Saginaw, MI
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
MCVI - St. Mary's of Michigan
mi
from
Saginaw, MI
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
The Mayo Clinic
mi
from
Rochester, MN
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Weill Medical College of Cornell University
mi
from
New York, NY
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Duke Univ Med Ctr
mi
from
Durham, NC
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
East Tennessee Cardiovascular Surgery Group
mi
from
Knoxville, TN
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
East Tennessee Cardiovascular Surgery Group
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Texas Heart Institute
mi
from
Houston, TX
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Texas Heart Institute
mi
from
Houston, TX
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Sentara Heart Hospital
mi
from
Norfolk, VA
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Sentara Heart Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Virginia Commonwealth University
mi
from
Richmond, VA
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Charleston Area Medical Center (CAMC)
mi
from
Charleston, WV
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Charleston Area Medical Center (CAMC)
mi
from
Charleston, WV
Click here to add this to my saved trials
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated:  7/21/2015
Foothills Medical Centre
mi
from
Calgary,
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
Status: Enrolling
Updated: 7/21/2015
Foothills Medical Centre
mi
from
Calgary,
Click here to add this to my saved trials
Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery
CONSERV - 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) - A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects Exposed to Cardio-pulmonary Bypass During Cardiac Surgery at High Risk of Bleeding
Status: Enrolling
Updated:  7/21/2015
Cardio-Thoracic Surgeons, P.C.
mi
from
Birmingham, AL
Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery
CONSERV - 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) - A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects Exposed to Cardio-pulmonary Bypass During Cardiac Surgery at High Risk of Bleeding
Status: Enrolling
Updated: 7/21/2015
Cardio-Thoracic Surgeons, P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery
CONSERV - 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) - A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects Exposed to Cardio-pulmonary Bypass During Cardiac Surgery at High Risk of Bleeding
Status: Enrolling
Updated:  7/21/2015
Universitaetsklinikum Aachen AoeR
mi
from
Aachen,
Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery
CONSERV - 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) - A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects Exposed to Cardio-pulmonary Bypass During Cardiac Surgery at High Risk of Bleeding
Status: Enrolling
Updated: 7/21/2015
Universitaetsklinikum Aachen AoeR
mi
from
Aachen,
Click here to add this to my saved trials
Comparison of Forced Air and Conductive Patient Heating Systems During Ambulatory Surgeries
Status: Enrolling
Updated:  7/22/2015
Fox Valley Orthopedics
mi
from
Geneva, IL
Comparison of Forced Air and Conductive Patient Heating Systems During Ambulatory Surgeries
Status: Enrolling
Updated: 7/22/2015
Fox Valley Orthopedics
mi
from
Geneva, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
University of Alabama
mi
from
Birmingham, AL
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
Loma Linda Medical Center
mi
from
Loma Linda, CA
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
Loma Linda Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
Jackson Memorial Hospital
mi
from
Miami, FL
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
University of Miami
mi
from
Miami, FL
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
South Miami Hospital
mi
from
Miami, FL
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
South Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
Crossroads Research Inc.
mi
from
Owings Mills, MD
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
Crossroads Research Inc.
mi
from
Owings Mills, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
Chesapeake Research Group
mi
from
Pasadena, MD
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
Chesapeake Research Group
mi
from
Pasadena, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
Brigham and Women's Hosp
mi
from
Boston, MA
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
University of Missouri Health Care
mi
from
Columbia, MO
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
University of Missouri Health Care
mi
from
Columbia, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
NYU School of Medicine
mi
from
New York, NY
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
Mount Sinai School of Medicine
mi
from
New York, NY
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
SUNY Upstate Medical Center
mi
from
Syracuse, NY
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
SUNY Upstate Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated:  7/22/2015
VAMC
mi
from
Durham, NC
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Status: Enrolling
Updated: 7/22/2015
VAMC
mi
from
Durham, NC
Click here to add this to my saved trials